Soligenix shares surge after FDA granted orphan drug designation to dusquetide for Behçet’s Disease, boosting prospects for rare disease treatment.
Soligenix shares surge after FDA granted orphan drug designation to dusquetide for Behçet’s Disease, boosting prospects for rare disease treatment.
Copyright © Louis Velazquez. All Rights Reserved.